Background
Over the past 20 years, acute coronary syndrome with ST-segment elevation (ST-segment elevation myocardial infarction [STEMI] ) has seen a remarkable transformation in its prognosis. A net decrease in the mortality of patients with STEMI has been observed in French registries conducted every 5 years, namely USIK in 1995 [1] and USIC in 2000 [2] , followed by the French registry of acute ST-elevation or non-ST-elevation myocardial infarction (FAST-MI) in 2005 [3] and 2010 [4] . Accordingly, the 30-day mortality has decreased drastically from 13.7% in 1995 to 4.4% in 2010 [3, 4] .
Such a reduction in mortality is correlated with better management of STEMI not only as a result of greater access to coronary angioplasty, drug optimization and enhancements in both technology and angioplasty equipment, but also as a result of patient population characteristics (younger, more likely to be women) [5] . These results are extremely encouraging for the acute management of STEMI. However, clinical studies, as well as other American and European [6] [7] [8] registries, report more subtle results [9, 10] . This difference is possibly explained by the fact that the patients enrolled in FAST-MI are those hospitalized exclusively in cardiac intensive care units (CICUs). It would thus appear both useful and important to compare these selected data with a population obtained from the Échan-tillon généraliste des bénéficiaires (EGB; general sample of beneficiaries). Indeed, this database, the validity of which we have shown previously in the field of heart failure, allows for a more tailored approach to daily clinical practice [11, 12] (indexing of all managed STEMI patients even if not hospitalized in CICUs).
The objective of this study was to compare data on patients hospitalized for STEMI obtained from these two French registries (FAST-MI and EGB).
Methods

FAST-MI 2010 registry
The FAST-MI 2010 registry encompassed 213/279 (76.3%) CICUs distributed in 149 public hospitals (including 38 university hospital centres [17.8%] ), 62 private centres and two military centres.
Inclusion criteria for the FAST-MI 2010 registry were as follows: patients aged ≥ 18 years who agreed to participate in the study and were admitted to the CICU for acute coronary syndrome within 48 hours after the onset of symptoms over a period of 1 month (October 2010). Exclusion criteria were: any symptoms lasting > 48 hours after the first call; and iatrogenic infarctions.
EGB database
Data were extracted from the EGB database, which comprises a representative 1/97th random sample of the population covered by the French national health insurance system (approximately 80% of the French population) [13, 14] . The EGB database currently includes more than 600,000 beneficiaries, and has been used widely for public health and pharmacoepidemiological purposes for more than 5 years [15] [16] [17] [18] [19] .
Since 2005, the EGB database has included basic demographic data and has prospectively collected all claims for visits to physicians and exhaustive claims for all reimbursed drugs dispensed in retail pharmacies (including dates of prescription and dispensing, and quantities delivered). Medications are identified by their Anatomical therapeutic chemical class codes, which are included in the EGB database. The EGB database also contains data collected by the Programme de médicalisation des systèmes d'information (PMSI; programme for medicalization of information systems) in healthcare institutions (medical and surgical departments); thus, during the patient's stay, principal diagnoses and associated diagnoses are available, coded according to the International classification of diseases 10th edition (ICD-10). Associated diagnoses represent a proxy for comorbidity assessment and identification of triggering factors. All medical procedures performed during each stay are identified with their specific codes from the Common classification of medical procedures. The EGB database also includes registration of the date of death, recorded automatically from the Institut national de la statistique et des études économiques (INSEE; National institute for statistics and economic studies), independent of the use or not of health care resources.
Only hospitalized patients with an ICD-10 code of STEMI are included (codes I21.0× to I21.9×, except for code I21.4, which is defined as subendocardial infarction). 
Patient inclusion in the present study
Only those patients treated for STEMI stemming from the initial publication of FAST-MI 2010 [5] were included in the present study. Patients included from the EGB database were hospitalized patients, with a discharge date during the year 2010 and at least one ICD-10 code of STEMI as principal diagnosis.
Patients with a non-STEMI in the EGB database or the FAST-MI 2010 registry, as well as those who died before hospital admission, were not included. Information regarding death was directly accessible, whether indicated in the INSEE or via the PMSI and recorded by the French public administration. Treatment data included drugs dispensed in pharmacies, within 60 days after hospitalization for STEMI, that had been the subject of a reimbursement claim.
Statistical analysis
All analyses were performed using Stata software, version 12 (StataCorp, College Station, TX, USA). All analyses were done for a two-sided type I error of ␣ = 5%. Population data are described as frequencies and associated percentages for categorical variables and as means ± standard deviations for quantitative variables (age). Quantitative data were compared between groups (EGB 2010 and FAST-MI 2010) using Student's t-test, according to their assumptions (normality studied by the Shapiro-Wilk test and homoscedasticity by the Fisher-Snedecor test). Comparisons concerning categorical data were performed using the 2 test or, when appropriate, Fisher's exact test. Then, a univariate analysis of 30-day mortality was performed using logistic regression, followed by a multivariable logistic regression model to determine predictive factors of 30-day mortality, by backward and forward stepwise selection of factors considered significant in the univariate analysis and according to clinical relevance variables [20, 21] . Results are presented as odds ratios (ORs; for univariate analysis) and adjusted ORs (for multivariable analysis) with associated 95% confidence intervals (CIs).
Results
Baseline characteristics
During the year 2010, 403 patients with a diagnosis of STEMI were listed in the EGB database. In the FAST-MI 2010 registry, 56% of patients (n = 1716/3079) were included with the same diagnosis. Patients in the EGB database were older (67.2 ± 15.3 vs 63.3 ± 14.5 years; P < 0.001), were more often women (36.0% vs 24.7%; P < 0.001) and were less frequently treated in university hospital centres (27.1% vs 37.0%; P = 0.001) ( Table 1) .
The majority of cardiovascular risk factors and comorbidities were similar. However, patients in the EGB database more often had diabetes (22.1% vs 16.5%; P = 0.008), chronic renal failure (6.4% vs 2.1%; P < 0.001), peripheral artery disease (9.4% vs 4.8%; P < 0.001) and a history of coronary stent angioplasty (15.6% vs 10.2%; P = 0.002), while fewer underwent coronary artery bypass graft surgery (2.5% vs 5.6%; P = 0.01). The estimated incidence of STEMI in the French population derived from the EGB population was 75/100,000.
Acute phase angiography and coronary angioplasty
Compared with patients in the EGB database, patients in the FAST-MI 2010 registry more frequently underwent coronary angiography (96.3% vs 75.2%; P < 0.001) and coronary stenting during hospitalization (86.7% vs 58.8%; P < 0.001) (Fig. 1) .
Drug treatment
Treatments at inclusion were similar in the EGB and FAST-MI 2010 populations (Table 2) . Upon hospital discharge, patients in the EGB database less frequently received dual antiplatelet therapy (P < 0.001), beta-blockers (P < 0.001), statins (P < 0.001) and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (P < 0.001).
Mortality
Mortality at 30 days was higher in the EGB database (10.2% vs 4.4%; P < 0.001). Multivariable analysis revealed that chronic kidney disease (OR: 6.08; 95% CI: 1.72-21.49; P = 0.005), age > 75 years (OR: 4.41; 95% CI: 1.18-16.49; P = 0.03) and history of heart failure (OR: 4.50; 95% CI: 1.12-18.09; P = 0.04) were associated with higher mortality (Table 3) .
Evolution of the EGB database between 2005 and 2013
Unlike database confirmed the increase in the rate of angioplasty (P < 0.001).
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Discussion
This study enabled us to compare data from patients hospitalized for STEMI obtained from a validated registry stemming from clinical practice (FAST-MI 2010) and from the French national health insurance system (EGB database).
The EGB database appears valid in depicting this STEMI population, as shown previously by our group for heart failure [12] . Indeed, patients exhibited similar characteristics (comorbidities, cardiovascular risk factors, prevalence of young women), the effect of estimated STEMI was similar to that described in France (75/100,000 vs 78/100,000) [22] , and there was overlapping evolution of angiograms between the two registries over the past decade [23] . However, there were several differences between these two databases with regard to epidemiology (higher cardiovascular risk, older and greater proportion of women in the EGB database), initial management (less stenting in the EGB database), medical management (fewer prescriptions for STEMI drugs in the EGB database), as well as prognostic differences. Indeed, 30-day mortality was more than two-fold higher in the EGB database (10.5% vs 4.4%; P < 0.001). Both epidemiological and management differences may partly account for this poorer prognosis. The EGB database population -older, with a higher female:male ratio -was associated with a greater number of severe comorbidities (chronic kidney disease [+305%], peripheral artery disease [+195%], diabetes [+133%] and atrial fibrillation [+221%]). Accordingly, the FAST-MI 2010 registry revealed that women were found to have much later and less frequent recourse to angioplasty, and thus had a poorer prognosis, despite management in the CICU [24] . The design of the FAST-MI 2010 registry imposes inclusions secondary to hospitalization in the CICU, and therefore with optimal management of the STEMI. A segment of the more frail population, with a more uncertain diagnosis or poorer prognosis, is excluded from the registry (i.e. the population receiving medical treatment without hospitalization in the CICU). The EGB database, on the other hand, allows the study of this particular population.
Initial management also differs between the two registries. Revascularization after STEMI is less systematic in the EGB database (fewer coronary angiographies, less stenting). Participating centres in FAST-MI 2010 are typically university hospitals or centres equipped with an interventional cardiology platform, while EGB database patients can be hospitalized in centres with no CICU or coronary angiography room.
Finally, the study of the EGB database does not allow us to confirm the evolving patterns observed in the FAST-MI registry and other European registries [8, 9] . Unlike the FAST-MI registry, the included population may not necessarily receive CICU management [5] . Patients included in the CICU are younger and with fewer comorbidities. An analysis of the total population of the health insurance database appears to confirm these trends. Such a discrepancy may result from the limited sample size [22] . STEMI management strategies [23] . However, conducting such a registry is expensive and requires the active and comprehensive participation of coronary emergency unit personnel. These registries also have certain limitations: the FAST-MI 2010 registry only included 62% of patients admitted to CICUs (3079/4970 patients), with a low participation refusal rate of 5.6%; they are dependent on the voluntary participation of each centre; the exclusion criteria allow homogenization of the studied sample, but exclude a non-negligible subpopulation of patients (acute coronary syndromes persisting for > 48 hours or not hospitalized in the CICU); not all patients admitted for STEMI are managed in CICUs (elderly population, rural regions).
The comparison of patients hospitalized for STEMI from the Global registry of acute coronary events (GRACE) registry [25] revealed a lower mortality rate in patients enrolled in a randomized clinical trial (3.7%) compared with eligible non-enrolled patients included in a registry (7.1%). This difference was also observed among patients not participating in a randomized trial and ineligible for enrolment (11.4%; P < 0.001). These latter patients had the same characteristics as the EGB database patients (older, more often women, higher cardiovascular risk, longer history of surgical revascularization).
EGB database
The EGB database is a representative sample of beneficiaries covered by the health insurance system; it has already enabled assessment of medication adherence in coronary patients [13] and its effect on outcomes [26] . The EGB database has certain limitations. The collection of data is based on PMSI coding and, as such, certain clinical data (e.g. body mass index, tobacco use) and therapeutic data (e.g. prehospital fibrinolysis non-coded by Emergency medical services) are entered incorrectly or not entered at all. In addition, the EGB database does not contain any test results or paraclinical data (e.g. left ventricular ejection fraction, biological results). By contrast, it does contain all of the information regarding reimbursed care, albeit limited to the French metropolitan area [27] . Treatment at CICU discharge is extrapolated from filled prescriptions dispensed at 60 days, although this corresponds to that already described in the long-term study on medication adherence in patients with STEMI [27] . However, the EGB database may be more representative of patients managed for STEMI in France in different centres, including those with or without a CICU.
Conclusion
The FAST-MI registry is the gold standard for the epidemiological assessment of the management of patients hospitalized in CICUs for STEMI. However, the EGB database allows longitudinal follow-up, through passive and annual data collection. Although these two registries are different, their designs and the populations included provide complementary information, and offer a comprehensive and interesting view of patients treated for STEMI in France.
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